Psychotic versus non-psychotic major depressive disorder: A comparative naturalistic study

Asian Journal of Psychiatry

Volumn 6, Issue 4, 2013, Pages 333-337

  Buoli, Massimiliano ^a   Caldiroli, Alice ^a   Altamura, Alfredo Carlo ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Family history; Major psychotic depression; Remission

Indexed keywords

ARIPIPRAZOLE; CLOMIPRAMINE; DULOXETINE; ESCITALOPRAM; HALOPERIDOL; OLANZAPINE; PAROXETINE; QUETIAPINE; RISPERIDONE; SERTRALINE; VENLAFAXINE; ZIPRASIDONE;

ADULT; ARTICLE; BIPOLAR DISORDER; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSIVE PSYCHOSIS; DISEASE SEVERITY; FAMILY HISTORY; FEMALE; HAMILTON SCALE; HUMAN; LENGTH OF STAY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; PSYCHOSIS; PSYCHOTIC MAJOR DEPRESSION; REMISSION; SCHIZOPHRENIA;

ADULT; AGED; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PSYCHOTIC DISORDERS; SEVERITY OF ILLNESS INDEX;

EID: 84883810117     PISSN: 18762018     EISSN: 18762026     Source Type: Journal    
DOI: 10.1016/j.ajp.2013.02.003     Document Type: Article

References (31)

1. Altamura A.C., Glick I.D. Designing outcome studies to determine efficacy and safety of antipsychotics for 'real world' treatment of schizophrenia. International Journal of Neuropsychopharmacology 2010, 13(August (7)):971-973.
2. Bauer M., Whybrow P.C., Angst J., Versiani M., Möller H.J., World Federation of Societies Biological Psychiatry Task Force on Treatment Guidelines for Unipolar Depressive Disorders World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders. Part 1. Acute and continuation treatment of major depressive disorder. World Journal of Biological Psychiatry 2002, 3:5-43.
3. Bauer M., Bschor T., Pfennig A., Whybrow P.C., Angst J., Versiani M., Möller H.J., WFSBP Task Force on Unipolar Depressive Disorders World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders in primary care. World Journal of Biological Psychiatry 2007, 8:67-104.
4. Coryell W. Psychotic depression. Journal of Clinical Psychiatry 1996, 57:27-31.
5. Coryell W. The treatment of psychotic depression. Journal of Clinical Psychiatry 1998, 59:22-27.
6. Cubells J.F., Price L.H., Meyers B.S., Anderson G.M., Zabetian C.P., Alexopoulos G.S., Nelson J.C., Sanacora G., Kirwin P., Carpenter L., Malison R.T., Gelernter J. Genotype-controlled analysis of plasma dopamine beta-hydroxylase activity in psychotic unipolar major depression. Biological Psychiatry 2002, 51:358-364.
7. Cubells J.F., Sun X., Li W., Bonsall R.W., McGrath J.A., Avramopoulos D., Lasseter V.K., Wolyniec P.S., Tang Y.L., Mercer K., Pulver A.E., Elston R.C. Linkage analysis of plasma dopamine β-hydroxylase activity in families of patients with schizophrenia. Human Genetics 2011, 130:635-643.
8. Eranti S., Mogg A., Pluck G., Landau S., Purvis R., Brown R.G., Howard R., Knapp M., Philpot M., Rabe-Hesketh S., Romeo R., Rothwell J., Edwards D., McLoughlinm D.M. A randomized, controlled trial with 6-month follow-up of repetitive transcranial magnetic stimulation and electroconvulsive therapy for severe depression. American Journal of Psychiatry 2007, 164:73-81.
9. Farahani A., Correll C.U. Are antipsychotics or antidepressants needed for psychotic depression? A systematic review and meta-analysis of trials comparing antidepressant or antipsychotic monotherapy with combination treatment. Journal of Clinical Psychiatry 2012, 73:486-496.
10. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P) 2002, Biometrics Research, New York State Psychiatric Institute, New York.
11. Goes F.S., Sadler B., Toolan J., Zamoiski R.D., Mondimore F.M., Mackinnon D.F., Schweizer B., Bipolar Disorder Phenome Group, Raymond Depaulo J., Potash J.B. Psychotic features in bipolar and unipolar depression. Bipolar Disorders 2007, 9:901-906.
12. Goldstein J.M., Buka S.L., Seidman L.J., Tsuang M.T. Specificity of familial transmission of schizophrenia psychosis spectrum and affective psychoses in the New England family study's high-risk design. Archives of General Psychiatry 2010, 67:458-467.
13. Gonul A.S., Kula M., Bilgin A.G., Tutus A., Oguz A. The regional cerebral blood flow changes in major depressive disorder with and without psychotic features. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2004, 28:1015-1021.
14. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 1960, 23:56-62.
15. Kessing L.V. Subtypes of depressive episodes according to ICD-10: prediction of risk of relapse and suicide. Psychopathology 2003, 36:285-291.
16. Meyers B.S., Flint A.J., Rothschild A.J., Mulsant B.H., Whyte E.M., Peasley-Miklus C., Papademetriou E., Leon A.C., Heo M., STOP-PD Group A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD). Archives of General Psychiatry 2009, 66:838-847.
17. Nierenberg A.A., DeCecco L.M. Definitions of antidepressant treatment response, remission, nonresponse, partial response, and other relevant outcomes: a focus on treatment-resistant depression. Journal of Clinical Psychiatry 2001, 62:5-9.
18. Ohayon M.M., Schatzberg A.F. Prevalence of depressive episodes with psychotic features in the general population. American Journal of Psychiatry 2002, 159:1855-1861.
19. Parker G., Roy K., Wilhelm K., Mitchell P., Hadzi-Pavlovic D. The nature of bipolar depression: implications for the definition of melancholia. Journal of Affective Disorders 2000, 59:217-224.
20. Paykel E.S. Partial remission, residual symptoms, and relapse in depression. Dialogues in Clinical Neuroscience 2008, 10:431-437.
21. Pintor L., Gastó C., Navarro V., Torres X., Fañanasm L. Relapse of major depression after complete and partial remission during a 2-year follow-up. Journal of Affective Disorders 2003, 73:237-244.
22. Rothschild A.J., Williamson D.J., Tohen M.F., Schatzberg A., Andersen S.W., Van Campen L.E., Sanger T.M., Tollefson G.D. A double-blind, randomized study of olanzapine and olanzapine/fluoxetine combination for major depression with psychotic features. Journal of Clinical Psychopharmacology 2004, 24:365-373.
23. Rush A.J. The varied clinical presentations of major depressive disorder. Journal of Clinical Psychiatry 2007, 68:4-10.
24. Schatzberg A.F., Rothschild A.J. Psychotic (delusional) major depression: should it be included as a distinct syndrome in DSM-IV?. American Journal of Psychiatry 1992, 149:733-745.
25. Schatzberg A.F., Posener J.A., DeBattista C., Kalehzan B.M., Rothschild A.J., Shear P.K. Neuropsychological deficits in psychotic versus nonpsychotic major depression and no mental illness. American Journal of Psychiatry 2000, 157:1095-1100.
26. Schatzberg A.F. New approaches to managing psychotic depression. Journal of Clinical Psychiatry 2003, 64:19-23.
27. Thakur M., Hays J., Krishnan K.R. Clinical, demographic and social characteristics of psychotic depression. Psychiatry Research 1999, 86:99-106.
28. van Loo H.M., de Jonge P., Romeijn J.W., Kessler R.C., Schoevers R.A. Data-driven subtypes of major depressive disorder: a systematic review. BMC Medicine 2012, 10:156.
29. Wittchen H.U., Jacobi F., Rehm J., Gustavsson A., Svensson M., Jönsson B., Olesen J., Allgulander C., Alonso J., Faravelli C., Fratiglioni L., Jennum P., Lieb R., Maercker A., van Os J., Preisig M., Salvador-Carulla L., Simon R., Steinhausen H.C. The size and burden of mental disorders and other disorders of the brain in Europe. European Neuropsychopharmacology 2011, 21:655-679.
30. Wood J.G., Joyce P.R., Miller A.L., Mulder R.T., Kennedy M.A. A polymorphism in the dopamine beta-hydroxylase gene is associated with "paranoid ideation" in patients with major depression. Biological Psychiatry 2002, 51:365-369.
31. Wijkstra J., Burger H., van den Broek W.W., Birkenhäger T.K., Janzing J.G., Boks M.P., Bruijn J.A., van der Loos M.L., Breteler L.M., Ramaekers G.M., Verkes R.J., Nolen W.A. Treatment of unipolar psychotic depression: a randomized, double-blind study comparing imipramine, venlafaxine, and venlafaxine plus quetiapine. Acta Psychiatrica Scandinavica 2010, 121:190-200.